Dr. Agarwal on the FDA Approval of Olaparib in HRR-Mutant mCRPC | OncLive
Dr. Agarwal on the FDA Approval of Olaparib in HRR-Mutant mCRPC | …
May 19, 2020
onclive.com
Managing Side Effects of PARP Inhibitors in mCRPC
Managing Side Effects of PARP Inhibitors in mCRPC
28 viewsNov 12, 2024
vumedi.com
FDA Expands AstraZeneca (AZN) Lynparza Label in Prostate Cancer
FDA Expands AstraZeneca (AZN) Lynparza Label in Prostate Cancer
Jun 2, 2023
nasdaq.com
What are PARP Inhibitors for Breast Cancer? | Lynparza (olaparib) Explained
4:09
What are PARP Inhibitors for Breast Cancer? | Lynparza (olaparib) Expl…
2.2K views10 months ago
YouTubeYerbba – Breast Cancer
Ep. 10: How Has the mCRPC Treatment Landscape Changed? | OncLive
Ep. 10: How Has the mCRPC Treatment Landscape Changed? | …
Mar 31, 2020
onclive.com
Breast cancer drug Lynparza reduces risk of death by 28% in patients diagnosed early, clinical trial shows | Fortune
Breast cancer drug Lynparza reduces risk of death by 28% in pa…
Dec 20, 2024
fortune.com
Dr. Maughan Discusses Abiraterone Plus Olaparib in mCRPC | OncLive
Dr. Maughan Discusses Abiraterone Plus Olaparib in mCRPC | OncLive
Jun 7, 2018
onclive.com
0:22
PARP Inhibitors Stops Cancer Cells from Repairing? Olaparib Explained!
6K views8 months ago
YouTubeYerbba – Breast Cancer
FDA clears Lynparza for prostate cancer treatment
Jun 7, 2023
foxsanantonio.com
Dr. Petrylak on Pivotal PARP Inhibitor Trials in mCRPC With DN…
Sep 28, 2020
onclive.com
Dr. Gulley Discusses a Phase II Study of Olaparib and Durvaluma…
Feb 10, 2018
onclive.com
8:39
#olaparib | Uses, Dosage, Side Effects & Mechanism | Lynparza
3.6K viewsOct 26, 2023
YouTubeHe-InFo
1:18
Exciting News for Breast Cancer Treatment We’re thrilled to annou…
1.1K viewsJul 3, 2024
FacebookBreast Cancer Network Australia
Dr. Gulley on Take Home Message With Olaparib Plus Durvalumab in …
Feb 17, 2018
onclive.com
Treatment Selection Considerations in mCRPC | Targeted Oncology - I…
9 months ago
targetedonc.com
0:34
AstraZeneca, Merck get FDA approval for pancreatic cancer drug
Dec 30, 2019
Fox BusinessDaniella Genovese
AstraZeneca's Lynparza gets OK as first drug aimed at women with in…
Jan 12, 2018
delawareonline.com
5:40
PARP Inhibitors in Advanced Prostate Cancers
528 viewsJan 3, 2019
YouTubeOncLive
Lynparza and Breast Cancer: Study Finds Reduced Recurrence Risk i…
Mar 11, 2025
pharmexec.com
7:10
Dr. Carlos Doti Explains How AstraZeneca's LYNPARZA Has Ch…
690 viewsJun 20, 2024
YouTubeDocWire
The Differences Between mCRPC and nmCRPC | Targeted Oncolog…
Jul 17, 2019
targetedonc.com
AstraZeneca breast cancer drug Lynparza is approved by EU regul…
Aug 4, 2022
thisismoney.co.uk
Dr. Dorff on Current Agents for Patients With mCRPC | OncLive
Nov 16, 2017
onclive.com
Treatment Sequencing in mCRPC: Evidence From VISION, TheraP, a…
154 views10 months ago
vumedi.com
3:26
#リムパーザ (Lynparza) | 基本情報, 効能, 注意すべき副作用, 用法・用量 …
1.6K viewsFeb 11, 2023
YouTubeHe-InFo
32:19
Patient-Centered Care in mCRPC: Exploring PARP Inhibitor
213 viewsMar 14, 2025
YouTubeMedscape
0:29
Women living with BRCA-related ovarian cancer will have access t…
4.5K viewsOct 21, 2020
Facebook7NEWS Brisbane
Access to Cabazitaxel vs. 177Lu-PSMA-617 in mCRPC: Challenges …
5 months ago
vumedi.com
11:49
BRCA & PARP Inhibitors: Targeted Chemotherapy | #MarkScholzMD #…
5.8K viewsJun 1, 2023
YouTubeProstate Cancer Research Institute
Dr. Grivas on Comparisons Between ATM and BRCA1/2 Mutations in m…
4 weeks ago
onclive.com
See more videos
Static thumbnail place holder